STAT3 is over-activated within CD163pos bone marrow macrophages in both Multiple Myeloma and the benign pre-condition MGUS
出版年份 2021 全文链接
标题
STAT3 is over-activated within CD163pos bone marrow macrophages in both Multiple Myeloma and the benign pre-condition MGUS
作者
关键词
-
出版物
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-06-01
DOI
10.1007/s00262-021-02952-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- STAT3 inhibition specifically in human monocytes and macrophages by CD163-targeted corosolic acid-containing liposomes
- (2019) Morten Nørgaard Andersen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Circulating extracellular vesicle‐associated CD163 and CD206 in multiple myeloma
- (2019) Sarah L. Kvorning et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- STAT3 in Tumor-Associated Myeloid Cells: Multitasking to Disrupt Immunity
- (2018) Yu-Lin Su et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The bone-marrow niche in MDS and MGUS: implications for AML and MM
- (2018) Irene M. Ghobrial et al. Nature Reviews Clinical Oncology
- Macrophages are exploited from an innate wound healing response to facilitate cancer metastasis
- (2018) Tamara Muliaditan et al. Nature Communications
- Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activation
- (2017) Nathan De Beule et al. JOURNAL OF PATHOLOGY
- Prognostic value of diametrically polarized tumor-associated macrophages in multiple myeloma
- (2017) Xinyi Chen et al. Oncotarget
- Pro-inflammatory State in Monoclonal Gammopathy of Undetermined Significance and in Multiple Myeloma Is Characterized by Low Sialylation of Pathogen-Specific and Other Monoclonal Immunoglobulins
- (2017) Adrien Bosseboeuf et al. Frontiers in Immunology
- Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy
- (2016) Yoshihiro Komohara et al. ADVANCED DRUG DELIVERY REVIEWS
- Evaluation of the potential therapeutic benefits of macrophage reprogramming in multiple myeloma
- (2016) A. Gutierrez-Gonzalez et al. BLOOD
- MGUS to myeloma: a mysterious gammopathy of underexplored significance
- (2016) M. V. Dhodapkar BLOOD
- Molecular Pathways: Deciphering Mechanisms of Resistance to Macrophage-Targeted Therapies
- (2016) Daniela F. Quail et al. CLINICAL CANCER RESEARCH
- Strategy of STAT3β cell-specific expression in macrophages exhibits antitumor effects on mouse breast cancer
- (2015) W Dang et al. GENE THERAPY
- Tumor-associated macrophages and extracellular matrix metalloproteinase inducer in prognosis of multiple myeloma
- (2015) S Panchabhai et al. LEUKEMIA
- The novel biomarker of alternative macrophage activation, soluble mannose receptor (sMR/sCD206): Implications in multiple myeloma
- (2015) Morten N. Andersen et al. LEUKEMIA RESEARCH
- IL10-driven STAT3 signalling in senescent macrophages promotes pathological eye angiogenesis
- (2015) Rei Nakamura et al. Nature Communications
- The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells
- (2015) Jinheng Wang et al. Oncotarget
- Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple Myeloma
- (2015) J. L. Jensen et al. Cancer Immunology Research
- Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma
- (2014) Morten N. Andersen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Tumor-Associated Macrophages: From Mechanisms to Therapy
- (2014) Roy Noy et al. IMMUNITY
- International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
- (2014) S Vincent Rajkumar et al. LANCET ONCOLOGY
- Serial exome analysis of disease progression in premalignant gammopathies
- (2014) S Zhao et al. LEUKEMIA
- Tumor-associated macrophages as a prognostic parameter in multiple myeloma
- (2013) Elif Suyanı et al. ANNALS OF HEMATOLOGY
- Clinical significance of macrophage heterogeneity in human malignant tumors
- (2013) Yoshihiro Komohara et al. CANCER SCIENCE
- A soluble form of the macrophage-related mannose receptor (MR/CD206) is present in human serum and elevated in critical illness
- (2013) Sidsel Rødgaard-Hansen et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Macrophage biology in development, homeostasis and disease
- (2013) Thomas A. Wynn et al. NATURE
- Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells
- (2012) Maciej Bogdan Maniecki et al. INTERNATIONAL JOURNAL OF CANCER
- Efficient intracellular drug-targeting of macrophages using stealth liposomes directed to the hemoglobin scavenger receptor CD163
- (2012) Anders Etzerodt et al. JOURNAL OF CONTROLLED RELEASE
- Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells
- (2012) D Kim et al. LEUKEMIA
- PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma
- (2012) Y Zheng et al. LEUKEMIA
- Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature
- (2012) Qiong-wen Zhang et al. PLoS One
- Targeting Stat3 in the Myeloid Compartment Drastically Improves the In vivo Antitumor Functions of Adoptively Transferred T Cells
- (2010) A. Herrmann et al. CANCER RESEARCH
- Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma
- (2010) Horlad Hasita et al. CANCER SCIENCE
- Macrophage Diversity Enhances Tumor Progression and Metastasis
- (2010) Bin-Zhi Qian et al. CELL
- Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
- (2010) Subhra K Biswas et al. NATURE IMMUNOLOGY
- Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
- (2009) O. Landgren et al. BLOOD
- Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis
- (2009) Y. Zheng et al. BLOOD
- “Re-educating” tumor-associated macrophages by targeting NF-κB
- (2008) Thorsten Hagemann et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Bone marrow microenvironment and the identification of new targets for myeloma therapy
- (2008) K Podar et al. LEUKEMIA
- Pathogenesis and progression of monoclonal gammopathy of undetermined significance
- (2008) J Bladé et al. LEUKEMIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now